Diphtheria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Diphtheria Pipeline Drugs Market Report Overview
Diphtheria is a bacterial infection that affects the membranes of the throat and nose. The Diphtheria pipeline drugs market research report provides comprehensive information on the therapeutics under development for Diphtheria (Infectious Disease), complete with analysis by stage of development, drug target, route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report reviews key players involved in therapeutic development for Diphtheria and features dormant and discontinued projects.
Diphtheria Pipeline Drugs Market Segmentation by Targets
The key targets in the Diphtheria pipeline drugs market are Diphtheria Toxin, Tetanus Toxin, Pertussis Toxin, Haemophilus influenzae Lipooligosaccharide, Bordetella pertussis Pertactin, and Hemagglutinin.
Diphtheria Pipeline Drugs Market Analysis, by Targets
For more Diphtheria pipeline drugs market target insights, download a free report sample
Diphtheria Pipeline Drugs Market Segmentation by Routes of Administration
Some of the key routes of administration in the Diphtheria pipeline drugs market are intramuscular, subcutaneous, and oral.
Diphtheria Pipeline Drugs Market Analysis, by Routes of Administration
For more routes of administration insights into Diphtheria pipeline drugs market, download a free report sample
Diphtheria Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the Diphtheria pipeline drugs market are toxoid vaccine, vaccine, inactivated vaccine, subunit vaccine, conjugate vaccine, antibody, and monoclonal antibody.
Diphtheria Pipeline Drugs Market Analysis, by Molecule Types
For more molecule type insights into the Diphtheria pipeline drugs market, download a free report sample
Competitive Landscape
Some of the leading companies in the Diphtheria pipeline drugs market are CanSino Biologics Inc, AIM Vaccine Co Ltd, Serum Institute of India Pvt Ltd, Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, BioNet-Asia Co Ltd, Chengdu Olymvax Biopharmaceuticals Inc, KM Biologics Co Ltd, LG Chem Ltd, and Suzhou Weichao Biotechnology Co Ltd.
Diphtheria Pipeline Drugs Market Analysis, by Companies
To know more about the companies in the Diphtheria pipeline drugs market, download a free report sample
Diphtheria Pipeline Drugs Market Report Overview
| Key Targets | Diphtheria Toxin, Tetanus Toxin, Pertussis Toxin, Haemophilus influenzae Lipooligosaccharide, Bordetella pertussis Pertactin, and Hemagglutinin |
| Key Routes of Administration | Intramuscular, Subcutaneous, and Oral |
| Key Molecule Types | Toxoid Vaccine, Vaccine, Inactivated Vaccine, Subunit Vaccine, Conjugate Vaccine, Antibody, and Monoclonal Antibody |
| Leading Companies | CanSino Biologics Inc, AIM Vaccine Co Ltd, Serum Institute of India Pvt Ltd, Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, BioNet-Asia Co Ltd, Chengdu Olymvax Biopharmaceuticals Inc, KM Biologics Co Ltd, LG Chem Ltd, and Suzhou Weichao Biotechnology Co Ltd |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Diphtheria (Infectious Disease).
- Reviews of pipeline therapeutics for Diphtheria (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- Reviews of key companies involved in Diphtheria (Infectious Disease) therapeutics and enlists all their major and minor projects.
- Evaluation of Diphtheria (Infectious Disease) therapeutics based on drug target, route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news related to pipeline therapeutics for Diphtheria (Infectious Disease).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Diphtheria (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Diphtheria (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Amogen Pharma Pvt Ltd
Beijing Minhai Biotechnology Co Ltd
Beijing Tiantan Biological Products Co Ltd
Biken Co Ltd
Biological E Ltd
BioNet-Asia Co Ltd
Boryung Pharmaceutical Co Ltd
CanSino Biologics Inc
Changchun Bcht Biotechnology Co Ltd
Chengdu Kanghua Biological Products Co Ltd
Chengdu Olymvax Biopharmaceuticals Inc
Chongqing Zhifei Biological Products Co Ltd
Emergent BioSolutions Inc
GC Biopharma Corp
KM Biologics Co Ltd
LG Chem Ltd
MassBiologics
Novo Medi Sciences Pvt Ltd
Panacea Biotec Ltd
Sanofi
Serum Institute of India Pvt Ltd
Shantha Biotechnics Pvt Ltd
Suzhou Weichao Biotechnology Co Ltd
VaxForm LLC
Yunnan Watson Biotechnology Co Ltd
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Diphtheria pipeline drugs market?
The key targets in the Diphtheria pipeline drugs market are Diphtheria Toxin, Tetanus Toxin, Pertussis Toxin, Haemophilus influenzae Lipooligosaccharide, Bordetella pertussis Pertactin, and Hemagglutinin.
-
What are the key routes of administration in the Diphtheria pipeline drugs market?
The key routes of administration in the Diphtheria pipeline drugs market are intramuscular, subcutaneous, and oral.
-
What are the key molecule types in the Diphtheria pipeline drugs market?
The key molecule types in the Diphtheria pipeline drugs market are toxoid vaccine, vaccine, inactivated vaccine, subunit vaccine, conjugate vaccine, antibody, and monoclonal antibody.
-
Which are the leading companies in the Diphtheria pipeline drugs market?
Some of the leading companies in the Diphtheria pipeline drugs market are CanSino Biologics Inc, AIM Vaccine Co Ltd, Serum Institute of India Pvt Ltd, Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, BioNet-Asia Co Ltd, Chengdu Olymvax Biopharmaceuticals Inc, KM Biologics Co Ltd, LG Chem Ltd, and Suzhou Weichao Biotechnology Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Infectious Disease reports



